Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty

Omar M Said,1 Mohamed GA Saleh,2 Ahmed F Omar,2,3 Ahmed A Abdou,2 Ali Natag Riad Mostafa2 1Department of Ophthalmology, Faculty of Medicine, Fayoum University, Fayoum, Egypt; 2Department of Ophthalmology, Faculty of Medicine, Assiut University, Assiut, Egypt; 3University Hospitals Eye Institute and...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Said OM, Saleh MGA, Omar AF, Abdou AA, Riad Mostafa AN
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	difluprednate penetrating keratoplasty graft rejection. Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/dd3089a524f34ffe993f4d626829ad07
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:dd3089a524f34ffe993f4d626829ad07
record_format	dspace
spelling	oai:doaj.org-article:dd3089a524f34ffe993f4d626829ad072021-12-02T10:29:26ZTopical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty1177-5483https://doaj.org/article/dd3089a524f34ffe993f4d626829ad072020-10-01T00:00:00Zhttps://www.dovepress.com/topical-difluprednate-for-early-corneal-graft-rejection-after-penetrat-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Omar M Said,1 Mohamed GA Saleh,2 Ahmed F Omar,2,3 Ahmed A Abdou,2 Ali Natag Riad Mostafa2 1Department of Ophthalmology, Faculty of Medicine, Fayoum University, Fayoum, Egypt; 2Department of Ophthalmology, Faculty of Medicine, Assiut University, Assiut, Egypt; 3University Hospitals Eye Institute and the Department of Ophthalmology and Visual Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USACorrespondence: Ahmed F Omar Tel +1 216 844-7230Email ahmed.omar@uhhospitals.orgPurpose: To evaluate the safety and efficacy of topical difluprednate ophthalmic emulsion use for prophylaxis of corneal graft rejection in patients undergoing penetrating keratoplasty.Methods: This study reviewed the charts of patients undergoing penetrating keratoplasty who were treated with difluprednate (DP) ophthalmic emulsion postoperatively. At each follow-up visit, patients were followed for signs of graft rejection, cataract development, and intraocular pressure rise in addition to routine ocular examination.Results: The charts of 36 patients (38 eyes) who underwent penetrating keratoplasty (PKP) (27 eyes) and PKP triple (11 eyes) were reviewed. All eyes were followed up for at least 8 months postoperatively. Five grafts developed rejection and three grafts subsequently failed. Six eyes had an increase of IOP that required use of antiglaucoma drops. Three eyes were switched from difluprednate to prednisolone acetate (PA) after persistent rise of IOP failed to respond to antiglaucoma drops. None of these cases needed glaucoma surgery. Two patients developed cataract during the follow-up period (out of 12 phakic eyes).Conclusion: Topical difluprednate is potentially effective and safe in preventing graft rejection after penetrating keratoplasty. Larger prospective clinical trials are warranted.Keywords: difluprednate, penetrating keratoplasty, graft rejectionSaid OMSaleh MGAOmar AFAbdou AARiad Mostafa ANDove Medical Pressarticledifluprednatepenetrating keratoplastygraft rejection.OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 3495-3498 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	difluprednate penetrating keratoplasty graft rejection. Ophthalmology RE1-994
spellingShingle	difluprednate penetrating keratoplasty graft rejection. Ophthalmology RE1-994 Said OM Saleh MGA Omar AF Abdou AA Riad Mostafa AN Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty
description	Omar M Said,1 Mohamed GA Saleh,2 Ahmed F Omar,2,3 Ahmed A Abdou,2 Ali Natag Riad Mostafa2 1Department of Ophthalmology, Faculty of Medicine, Fayoum University, Fayoum, Egypt; 2Department of Ophthalmology, Faculty of Medicine, Assiut University, Assiut, Egypt; 3University Hospitals Eye Institute and the Department of Ophthalmology and Visual Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USACorrespondence: Ahmed F Omar Tel +1 216 844-7230Email ahmed.omar@uhhospitals.orgPurpose: To evaluate the safety and efficacy of topical difluprednate ophthalmic emulsion use for prophylaxis of corneal graft rejection in patients undergoing penetrating keratoplasty.Methods: This study reviewed the charts of patients undergoing penetrating keratoplasty who were treated with difluprednate (DP) ophthalmic emulsion postoperatively. At each follow-up visit, patients were followed for signs of graft rejection, cataract development, and intraocular pressure rise in addition to routine ocular examination.Results: The charts of 36 patients (38 eyes) who underwent penetrating keratoplasty (PKP) (27 eyes) and PKP triple (11 eyes) were reviewed. All eyes were followed up for at least 8 months postoperatively. Five grafts developed rejection and three grafts subsequently failed. Six eyes had an increase of IOP that required use of antiglaucoma drops. Three eyes were switched from difluprednate to prednisolone acetate (PA) after persistent rise of IOP failed to respond to antiglaucoma drops. None of these cases needed glaucoma surgery. Two patients developed cataract during the follow-up period (out of 12 phakic eyes).Conclusion: Topical difluprednate is potentially effective and safe in preventing graft rejection after penetrating keratoplasty. Larger prospective clinical trials are warranted.Keywords: difluprednate, penetrating keratoplasty, graft rejection
format	article
author	Said OM Saleh MGA Omar AF Abdou AA Riad Mostafa AN
author_facet	Said OM Saleh MGA Omar AF Abdou AA Riad Mostafa AN
author_sort	Said OM
title	Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty
title_short	Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty
title_full	Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty
title_fullStr	Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty
title_full_unstemmed	Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty
title_sort	topical difluprednate for early corneal graft rejection after penetrating keratoplasty
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/dd3089a524f34ffe993f4d626829ad07
work_keys_str_mv	AT saidom topicaldifluprednateforearlycornealgraftrejectionafterpenetratingkeratoplasty AT salehmga topicaldifluprednateforearlycornealgraftrejectionafterpenetratingkeratoplasty AT omaraf topicaldifluprednateforearlycornealgraftrejectionafterpenetratingkeratoplasty AT abdouaa topicaldifluprednateforearlycornealgraftrejectionafterpenetratingkeratoplasty AT riadmostafaan topicaldifluprednateforearlycornealgraftrejectionafterpenetratingkeratoplasty
_version_	1718397207781048320

Topical Difluprednate for Early Corneal Graft Rejection After Penetrating Keratoplasty

Ejemplares similares